vs
Fiverr International Ltd.（FVRR）与ICU MEDICAL INC（ICUI）财务数据对比。点击上方公司名可切换其他公司
ICU MEDICAL INC的季度营收约是Fiverr International Ltd.的1.9倍（$540.7M vs $287.8M），Fiverr International Ltd.净利率更高（1.9% vs -2.9%，领先4.8%），Fiverr International Ltd.自由现金流更多（$52.1M vs $36.0M），过去两年Fiverr International Ltd.的营收复合增速更高（29.5% vs -2.3%）
Fiverr International Ltd.运营全球在线自由职业服务平台，连接160余个国家的企业客户与独立创作者，提供数字营销、平面设计、编程、文案撰写、视频剪辑等多领域专业服务，满足各类客户灵活的按需用工需求。
ICU医疗是总部位于美国加利福尼亚州圣克莱门特的医疗科技企业，专注于研发预防血流感染、保护医护人员免受传染病或危险药物侵害的医疗产品，产品线覆盖静脉治疗用品、输液泵、无针血管通路设备、定制输液套装、危险药物密闭处理系统、传感导管以及无针封闭式血液采样系统等。
FVRR vs ICUI — 直观对比
营收规模更大
ICUI
是对方的1.9倍
$287.8M
净利率更高
FVRR
高出4.8%
-2.9%
自由现金流更多
FVRR
多$16.1M
$36.0M
两年增速更快
FVRR
近两年复合增速
-2.3%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $287.8M | $540.7M |
| 净利润 | $5.4M | $-15.7M |
| 毛利率 | 82.5% | 37.5% |
| 营业利润率 | -3.5% | 1.0% |
| 净利率 | 1.9% | -2.9% |
| 营收同比 | — | -14.1% |
| 净利润同比 | — | 34.0% |
| 每股收益（稀释后） | — | $-0.63 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FVRRICUI
| Q4 25 | — | $540.7M | ||
| Q3 25 | $287.8M | $537.0M | ||
| Q2 25 | $188.2M | $548.9M | ||
| Q1 25 | $93.5M | $604.7M | ||
| Q4 24 | — | $629.8M | ||
| Q3 24 | $269.9M | $589.1M | ||
| Q2 24 | $177.3M | $596.5M | ||
| Q1 24 | $88.0M | $566.7M |
净利润FVRRICUI
| Q4 25 | — | $-15.7M | ||
| Q3 25 | $5.4M | $-3.4M | ||
| Q2 25 | $4.1M | $35.3M | ||
| Q1 25 | $788.0K | $-15.5M | ||
| Q4 24 | — | $-23.8M | ||
| Q3 24 | $-1.0M | $-33.0M | ||
| Q2 24 | $-4.0M | $-21.4M | ||
| Q1 24 | $-4.3M | $-39.5M |
毛利率FVRRICUI
| Q4 25 | — | 37.5% | ||
| Q3 25 | 82.5% | 37.4% | ||
| Q2 25 | 83.3% | 37.9% | ||
| Q1 25 | 83.5% | 34.7% | ||
| Q4 24 | — | 36.1% | ||
| Q3 24 | 82.8% | 34.8% | ||
| Q2 24 | 82.4% | 34.8% | ||
| Q1 24 | 82.2% | 32.7% |
营业利润率FVRRICUI
| Q4 25 | — | 1.0% | ||
| Q3 25 | -3.5% | 2.6% | ||
| Q2 25 | -3.4% | 1.9% | ||
| Q1 25 | -4.4% | 2.1% | ||
| Q4 24 | — | 6.0% | ||
| Q3 24 | -5.0% | 1.4% | ||
| Q2 24 | -6.3% | 1.3% | ||
| Q1 24 | -8.1% | -1.9% |
净利率FVRRICUI
| Q4 25 | — | -2.9% | ||
| Q3 25 | 1.9% | -0.6% | ||
| Q2 25 | 2.2% | 6.4% | ||
| Q1 25 | 0.8% | -2.6% | ||
| Q4 24 | — | -3.8% | ||
| Q3 24 | -0.4% | -5.6% | ||
| Q2 24 | -2.3% | -3.6% | ||
| Q1 24 | -4.9% | -7.0% |
每股收益（稀释后）FVRRICUI
| Q4 25 | — | $-0.63 | ||
| Q3 25 | — | $-0.14 | ||
| Q2 25 | — | $1.43 | ||
| Q1 25 | — | $-0.63 | ||
| Q4 24 | — | $-0.97 | ||
| Q3 24 | — | $-1.35 | ||
| Q2 24 | — | $-0.88 | ||
| Q1 24 | — | $-1.63 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $133.5M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $362.6M | $2.1B |
| 总资产 | $1.1B | $4.1B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资FVRRICUI
| Q4 25 | — | — | ||
| Q3 25 | $133.5M | — | ||
| Q2 25 | $578.4M | — | ||
| Q1 25 | $133.5M | — | ||
| Q4 24 | — | $308.6M | ||
| Q3 24 | $183.7M | $312.5M | ||
| Q2 24 | $183.7M | $302.6M | ||
| Q1 24 | $183.7M | $251.4M |
股东权益FVRRICUI
| Q4 25 | — | $2.1B | ||
| Q3 25 | $362.6M | $2.1B | ||
| Q2 25 | $404.9M | $2.1B | ||
| Q1 25 | $362.6M | $2.0B | ||
| Q4 24 | — | $2.0B | ||
| Q3 24 | $355.8M | $2.0B | ||
| Q2 24 | $355.8M | $2.0B | ||
| Q1 24 | $355.8M | $2.1B |
总资产FVRRICUI
| Q4 25 | — | $4.1B | ||
| Q3 25 | $1.1B | $4.1B | ||
| Q2 25 | $1.1B | $4.1B | ||
| Q1 25 | $1.1B | $4.2B | ||
| Q4 24 | — | $4.2B | ||
| Q3 24 | $1.0B | $4.3B | ||
| Q2 24 | $1.0B | $4.3B | ||
| Q1 24 | $1.0B | $4.3B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $53.0M | $60.6M |
| 自由现金流经营现金流 - 资本支出 | $52.1M | $36.0M |
| 自由现金流率自由现金流/营收 | 18.1% | 6.6% |
| 资本支出强度资本支出/营收 | 0.3% | 4.6% |
| 现金转化率经营现金流/净利润 | 9.81× | — |
| 过去12个月自由现金流最近4个季度 | $124.9M | $91.8M |
8季度趋势，按日历期对齐
经营现金流FVRRICUI
| Q4 25 | — | $60.6M | ||
| Q3 25 | $53.0M | $56.7M | ||
| Q2 25 | $42.2M | $11.2M | ||
| Q1 25 | $21.2M | $51.3M | ||
| Q4 24 | — | $40.2M | ||
| Q3 24 | $10.9M | $36.1M | ||
| Q2 24 | $32.2M | $82.0M | ||
| Q1 24 | $21.2M | $45.8M |
自由现金流FVRRICUI
| Q4 25 | — | $36.0M | ||
| Q3 25 | $52.1M | $27.6M | ||
| Q2 25 | $41.5M | $-8.5M | ||
| Q1 25 | $20.8M | $36.7M | ||
| Q4 24 | — | $16.1M | ||
| Q3 24 | $10.6M | $16.2M | ||
| Q2 24 | $31.5M | $62.5M | ||
| Q1 24 | $20.8M | $29.9M |
自由现金流率FVRRICUI
| Q4 25 | — | 6.6% | ||
| Q3 25 | 18.1% | 5.1% | ||
| Q2 25 | 22.0% | -1.5% | ||
| Q1 25 | 22.3% | 6.1% | ||
| Q4 24 | — | 2.6% | ||
| Q3 24 | 3.9% | 2.7% | ||
| Q2 24 | 17.8% | 10.5% | ||
| Q1 24 | 23.7% | 5.3% |
资本支出强度FVRRICUI
| Q4 25 | — | 4.6% | ||
| Q3 25 | 0.3% | 5.4% | ||
| Q2 25 | 0.4% | 3.6% | ||
| Q1 25 | 0.4% | 2.4% | ||
| Q4 24 | — | 3.8% | ||
| Q3 24 | 0.1% | 3.4% | ||
| Q2 24 | 0.4% | 3.3% | ||
| Q1 24 | 0.4% | 2.8% |
现金转化率FVRRICUI
| Q4 25 | — | — | ||
| Q3 25 | 9.81× | — | ||
| Q2 25 | 10.40× | 0.32× | ||
| Q1 25 | 26.90× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FVRR
暂无分部数据
ICUI
| Infusion Consumables | $284.7M | 53% |
| Infusion Systems | $176.3M | 33% |
| Vital Care | $79.7M | 15% |
